Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim...
Do drugs work better if taken by the clock? A new analysis published in this month’s issue of The Lancet journal’s eClinicalMedicine suggests: Yes, they do...